Neurocrine Biosciences reported $54.7M in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -33651000 79.36M
Acorda Therapeutics ACOR:US $ -13890000 387K
Agios Pharmaceuticals AGIO:US $ -97640000 3.5M
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Amgen AMGN:US $ 2176M 324M
Aptinyx Inc APTX:US $ -17105000 2.27M
Biogen BIIB:US $ 940.9M 409.4M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Cytokinetics CYTK:US $ -10874000 66.98M
Dynavax Technologies DVAX:US $ 127.67M 96.2M
Enanta Pharmaceuticals ENTA:US $ -32540000 1.31M
Exelixis EXEL:US $ 83.71M 463K
Gilead Sciences GILD:US $ 2029M 868M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
Intra Cellular Therapies ITCI:US $ -87923000 15.26M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Pfizer PFE:US $ 12099M 2104M
Prothena PRTA:US -43209000 5.26M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Repligen RGEN:US $ 58.99M 1.79M
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Teva Pharmaceutical TEVA:IT 734M 55M
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M
Vertex Pharmaceuticals VRTX:US $ 1119.3M 85.9M
Xoma XOMA:US $ -4767000 2.7M
YTE INCY:US $ 260.29M 132.62M